Precipio Expands ICE COLD-PCR™ Menu for Breast, Colon and Endometrial Cancers
23 oct. 2018 09h15 HE
|
Precipio, Inc.
Ultra-sensitive assays for PIK3CA exons 9 & 20 detect mutations that impact critical therapeutic decisions NEW HAVEN, Conn., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO),...